Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal Read More
Read moreMemory chip giant’s surge pushes South Korea’s Kospi to new record Read More
Read moreStablecoins, a form of cryptocurrency pegged to a real world asset, are becoming part of the global financial system, with...
Read moreAlso in this newsletter: Compromise in Italo-Swiss fight over Alpine fire tragedy costs Read More
Read moreThailand’s economy grew in Q1 due to strong demand and supply, but signs of Middle East conflict impacts emerged, notably...
Read moreNEW YORK — Edgewise Therapeutics Inc. (NASDAQ: EWTX) shares surged more than 23% Tuesday morning, climbing to around $38.83 as...
Read moreBy Katherine K. Chan, Reporter Elevated oil prices began to feed through food and utility costs, driving headline inflation to...
Read more(Bloomberg) — Ukrainian drones are regularly hitting targets deep inside Russia, reaching to the Ural Mountains and communities where most...
Read moreAccess Denied You don't have permission to access "http://www.ndtvprofit.com/business/mait-rejects-claims-of-mandatory-source-code-sharing-backs-meitys-framework" on this server. Reference #18.c7f5d217.1777948595.1202b1b2 https://errors.edgesuite.net/18.c7f5d217.1777948595.1202b1b2 Read More
Read moreChennai: Tamilaga Vettri Kazhagam (TVK) chief Vijay during a public meeting ahead of the Tamil Nadu Assembly elections, in Chennai,...
Read more© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin
© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin